Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D E Furst

Showing results (91-100 of 251) with videos related to

Pageof 26
Sort By:
Arthritis and Rheumatism|November 1, 1990
Aspirin, hydroxychloroquine, and hepatic enzyme abnormalities with methotrexate in rheumatoid arthritisJ F Fries, G Singh, L Lenert, et al.
Bailliere'S Best Practice & Research. Clinical Rheumatology|February 1, 2000
Pharmacotherapeutic combination strategies with disease-modifying antirheumatic drugs in established rheumatoid arthritisP L van Riel, C J Haagsma, D E Furst
Rheumatic Diseases Clinics of North America|August 26, 1998
Biologic agents and immunotherapy in rheumatoid arthritis. Progress and perspectiveW J Wallis, D E Furst, V Strand, et al.
Annals of the Rheumatic Diseases|October 16, 2002
Preliminary guidelines for diagnosing and treating tuberculosis in patients with rheumatoid arthritis in immunosuppressive trials or being treated with biological agentsD E Furst, J Cush, S Kaufmann, et al.
Clinical Pharmacology and Therapeutics|October 1, 1983
Availability of salicylate from salsalate and aspirinS H Dromgoole, S Cassell, D E Furst, et al.
The Journal of Rheumatology. Supplement|September 1, 1994
DC-ART: decreased inflammatory synovitisD E Furst, P Brooks, A N Malaviya, et al.
Rheumatology (Oxford, England)|January 26, 2000
Recapitulation of the round-table discussion--assessing the role of anti-tumour necrosis factor therapy in the treatment of rheumatoid arthritisD E Furst, E Keystone, R N Maini, et al.
Arthritis and Rheumatism|June 1, 1990
Biliary elimination of low-dose methotrexate in humansB Nuernberg, R Koehnke, M Solsky, et al.
Clinical and Experimental Rheumatology|November 7, 2001
Controversies in COX-2 inhibitor therapy: closing remarksS B Abramson, D E Furst, M C Hochberg, et al.
Journal of Clinical Pharmacology|November 1, 1983
Comparison of tolmetin kinetics in rheumatoid arthritis and matched healthy controlsD E Furst, S H Dromgoole, S Fow, et al.
Pageof 26

Showing results (91-100 of 251) with videos related to

Sort By:
Pageof 26
Arthritis and Rheumatism|November 1, 1990
Aspirin, hydroxychloroquine, and hepatic enzyme abnormalities with methotrexate in rheumatoid arthritisJ F Fries, G Singh, L Lenert, et al.
Bailliere'S Best Practice & Research. Clinical Rheumatology|February 1, 2000
Pharmacotherapeutic combination strategies with disease-modifying antirheumatic drugs in established rheumatoid arthritisP L van Riel, C J Haagsma, D E Furst
Rheumatic Diseases Clinics of North America|August 26, 1998
Biologic agents and immunotherapy in rheumatoid arthritis. Progress and perspectiveW J Wallis, D E Furst, V Strand, et al.
Annals of the Rheumatic Diseases|October 16, 2002
Preliminary guidelines for diagnosing and treating tuberculosis in patients with rheumatoid arthritis in immunosuppressive trials or being treated with biological agentsD E Furst, J Cush, S Kaufmann, et al.
Clinical Pharmacology and Therapeutics|October 1, 1983
Availability of salicylate from salsalate and aspirinS H Dromgoole, S Cassell, D E Furst, et al.
The Journal of Rheumatology. Supplement|September 1, 1994
DC-ART: decreased inflammatory synovitisD E Furst, P Brooks, A N Malaviya, et al.
Rheumatology (Oxford, England)|January 26, 2000
Recapitulation of the round-table discussion--assessing the role of anti-tumour necrosis factor therapy in the treatment of rheumatoid arthritisD E Furst, E Keystone, R N Maini, et al.
Arthritis and Rheumatism|June 1, 1990
Biliary elimination of low-dose methotrexate in humansB Nuernberg, R Koehnke, M Solsky, et al.
Clinical and Experimental Rheumatology|November 7, 2001
Controversies in COX-2 inhibitor therapy: closing remarksS B Abramson, D E Furst, M C Hochberg, et al.
Journal of Clinical Pharmacology|November 1, 1983
Comparison of tolmetin kinetics in rheumatoid arthritis and matched healthy controlsD E Furst, S H Dromgoole, S Fow, et al.
Pageof 26